MANKIND evidence report
Evidence date: 2026-10-01. Research observations only.
What can I do with this stock?
Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.
Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.
Today: intraday
Evidence unavailable
No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
- No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
Next week: five trading sessions
No qualifying opportunity
No candidate with a primary five-session horizon in the coherent source run.
- No candidate with a primary five-session horizon in the coherent source run.
Long term: one to three years
Research only
A financial screen alone does not establish an investment recommendation.
- A current, source-backed thesis and valuation review is required.
Investment evidence
- Statement coverage
- FULL_STATEMENTS
- Financial source retrieved
- 2026-09-22T14:01:49.794119+00:00
Metrics
- latest_annual_period
- 2026-03-31
- revenue
- 142776400000.0
- net_income
- 19129300000.0
- operating_cash_flow
- 25157000000.0
- free_cash_flow
- 18897400000.0
- total_assets
- 280795300000.0
- total_liabilities
- 115184800000.0
- total_equity
- 163003400000.0
- cash
- 4827700000.0
- total_debt
- 63115400000.0
- revenue_growth
- 0.16958510547666017
- earnings_growth
- -0.03919214851127095
- net_margin
- 0.1339808259628342
- roe
- 0.11735522081134504
- debt_to_equity
- 0.387202966318494
- cash_conversion
- 1.3151030095194283
- free_cash_flow_margin
- 0.13235660795481607
- trailing_pe
- 53.1674
- forward_pe
- 41.4938
- peg_ratio
- Not supplied
- price_to_book
- 6.569
- dividend_yield
- 0.0
Other positional research
No qualifying opportunity
No candidate at another positional horizon in the coherent source run.
- No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
- Decision ID
- decision-48f85699903384cc690596e1066be237f2d9dd21e73433dae8c1f51776c254da
- Policy
- stock-decisions-v1
- Evidence bundle hash
- a0ffb5ea7722cdf9b2965bf9be612f3c3b02b0684436eff799b2768d4b7ba8a0
- market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
- validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
- financial-statements: 9463dc2edc7ccb39aa2b67d04937aee47c7a84a9802ebbdc2b8e1022e456307a
- daily-price: 6726a2a30db46bcb805006b7b15375ff92899f5b5bde05c7ea060a41a58bb639
- Conditional research decisions are not orders or personalized position sizes.
- Scenario payoffs are assumptions, not probabilities or expected returns.
- A stop price does not guarantee a maximum loss through a gap or illiquidity.
Download the decision evidence as JSON
Numerical report available. Evidence briefing is queued or awaiting retry.
Cached observations and evidence limits
- Price source verification: REPAIRED.
- The cached closing price on 2026-10-01 was INR 2535.00.
- The trailing 5-session price return was 1.40%.
- The trailing 20-session price return was 6.00%.
- The trailing 60-session price return was 1.76%.
- The trailing 250-session price return was 2.10%.
- Average cached traded value over twenty sessions was INR 1,315,942,432.
- The closing price was -3.17% below its highest close in the available trailing year.
- Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-22T14:01:49.794119+00:00 from EODHD.
- The cached financial metric latest annual period is 2026-03-31.
- The cached financial metric revenue growth is 0.16958510547666017.
- The cached financial metric net margin is 0.1339808259628342.
- The cached financial metric roe is 0.11735522081134504.
- The cached financial metric debt to equity is 0.387202966318494.
- The cached financial metric cash conversion is 1.3151030095194283.
- The cached financial metric free cash flow margin is 0.13235660795481607.
- Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.